Merck touts expensive new COVID drug while dismissing cheap ivermectin

Written on October 2, 2021. Posted in PT Global Economy.

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In

Username or Email

Password

 Remember Me  

New User Registration

Choose a Username*

First Name*

Last Name*

Email*

Password

Confirm Password

*Required field